These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1325 related articles for article (PubMed ID: 33971376)

  • 21. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
    Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
    mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
    Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Shenoy N; Luchtel R; Gulani P
    BMC Med; 2020 Aug; 18(1):260. PubMed ID: 32814566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for Reopening a Nation in a SARS-CoV-2 Pandemic: A Path Forward.
    Baker TL; Greiner JV
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068853
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.
    Luks AM; Swenson ER
    Ann Am Thorac Soc; 2020 Sep; 17(9):1040-1046. PubMed ID: 32521167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.
    Oberemok VV; Laikova KV; Yurchenko KA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Jul; 69(7):635-640. PubMed ID: 32350571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteflazid® effectiveness for prevention and treatment of acute viral respiratory infections in the conditions of COVID-19.
    Grynevych O; Borshov S; Matyash V; Momotiuk L; Motuzka O; Yashchenko L
    Pol Merkur Lekarski; 2021 Aug; 49(292):255-265. PubMed ID: 34464364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.